Boston Life Sciences Announces the Publication of the Results of Phase I/II Study of Altropane for the Diagnosis of Parkinson's Disease.BOSTON--(BUSINESS WIRE)--April 30, 1998--Boston Life Sciences ue of Synapse synapse (sĭn`ăps), junction between various signal-transmitter cells, either between two neurons or between a neuron and a muscle or gland. A nerve impulse reaches the synapse through the axon, or transmitting end, of a nerve cell, or neuron. . In the clinical Phase I/II s. The reduction in striatal Altropane uptake in PD was statistically reduced compared to the healthy volunteers (p<0.001). The authors conclude, "...In the future, this e Neurons, I, II, and III," document the pre-clhese encouraging results in our Phase III study, which we have designed to test the hypothesis that Altropane-SPECT scanning can reliably differentiate early PD from othhe treatment of solid tumors; Therafectin, an oral drug for the treatment of Rheumatoid Arthritis rheumatoid arthritis Chronic, progressive autoimmune disease causing connective-tissue inflammation, mostly in synovial joints. It can occur at any age, is more common in women, and has an unpredictable course. ; Axogenesis Factor 1 (AF1), a Central Nervous System (CNS See Continuous net settlement. CNS See continuous net settlement (CNS). ) growth factor for the treatment of stroke and spinal cord injuries; and transcription factors that may control the expression re's full file on the Internet with Hyperlinks to your home page. URL URL in full Uniform Resource Locator Address of a resource on the Internet. The resource can be any type of file stored on a server, such as a Web page, a text file, a graphics file, or an application program. : http://www.businesswire.com |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion